Tracy Porter, the football legend notorious for sealing the New Orleans Saints' Super Bowl win in 2010, struggled with persistent knee pain for several seasons.
Biologics
A first-in-human phase I clinical trial in which neural stem cells were transplanted into chronic spinal cord injury patients produced improved motor and sensory function in three of four subjects with no adverse effects, according to results published in Cell…
While working in a burn unit at Baltimore-based John Hopkins University School of Medicine, PolarityTE founders Ned Swanson, MD, and Denver Lough, MD, PhD, grappled with the limited treatment options for patients. Inspired to provide new methods, they left their…
LifeVault Bio's GoodCell kit allows customers to bank their stem cells for future use, STAT reports, but not all stem cell researchers are on board.
Global asset manager Fidelity International invested $5.2 million in Cynata Therapeutics, an Australian stem cell and regenerative medicine company, Business Insider Australia reports.
Advertisement
The global spine biologics market is forecasted to grow at a compound annual growth rate of 4.09 percent between 2018 and 2022, according to a Technavio report.
DiscGenics principal investigator Domagoj Coric, MD, of Carolina Neurosurgery and Spine Associates in Charlotte, N.C., treated the first patient in the phase 1/phase 2 clinical trial of IDCT.
Organogenesis is a regenerative medicine company based in Canton, Mass., focused on developing products for the wound care, surgical and sports medicine markets.
Treating knee arthritis with NASHA (durolane hyaluronic acid) is a safe and effective procedure, according to a study in Open Access Rheumatology: Research and Reviews.
Here are the 14 major players in the global spine biologics market, according to an E Market Research report.